GI & Endoscopy

Sucampo Pharmaceuticals is focusing its efforts on growing its Amitiza digestive disease line, Zacks reports.

Effector Therapeutics is partnering with Pfizer and Merck to evaluate two immuno-oncology agents in patients with microsatellite stable colorectal cancer.

The global ingestible sensors market is poised for substantial growth, according to ReportsNReports analysts.

The American Board of Surgery is the latest professional organization to acknowledge the importance of surgical endoscopy, General Surgery News reports.

A study, published in Clinical Gastroenterology and Hepatology, examined psychological disorders in relation to gastrointestinal disorders.

Providence, R.I.-based University Gastroenterology has served the New England region for more than three decades.

Here are five updates on GI companies from the past week:

The American Gastroenterological Association released its statement on Senate Republicans' proposed healthcare legislation saying the bill would drastically limit Americans' access to healthcare.

Europeans have an increased risk of developing colorectal and other digestive cancers because of high alcohol consumption, a United European Gastroenterology report found.

Innovate Biopharmaceuticals agreed to acquire Monster Digital, an electronic camera and data storage company.